These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus. Syvänne M; Kahri J; Virtanen KS; Taskinen MR Circulation; 1995 Aug; 92(3):364-70. PubMed ID: 7634450 [TBL] [Abstract][Full Text] [Related]
45. Limited proteolysis of high density lipoprotein abolishes its interaction with cell-surface binding sites that promote cholesterol efflux. Mendez AJ; Oram JF Biochim Biophys Acta; 1997 Jun; 1346(3):285-99. PubMed ID: 9219913 [TBL] [Abstract][Full Text] [Related]
46. RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo. Bailey D; Jahagirdar R; Gordon A; Hafiane A; Campbell S; Chatur S; Wagner GS; Hansen HC; Chiacchia FS; Johansson J; Krimbou L; Wong NC; Genest J J Am Coll Cardiol; 2010 Jun; 55(23):2580-9. PubMed ID: 20513599 [TBL] [Abstract][Full Text] [Related]
47. Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma. Zhu Y; Bellosta S; Langer C; Bernini F; Pitas RE; Mahley RW; Assmann G; von Eckardstein A Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7585-90. PubMed ID: 9636193 [TBL] [Abstract][Full Text] [Related]
48. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity. Sparks DL; Frank PG; Neville TA Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105 [TBL] [Abstract][Full Text] [Related]
49. Displacement of apo A-I from HDL by apo A-II or its C-terminal helix promotes the formation of pre-beta1 migrating particles and decreases LCAT activation. Labeur C; Lambert G; Van Cauteren T; Duverger N; Vanloo B; Chambaz J; Vandekerckhove J; Castro G; Rosseneu M Atherosclerosis; 1998 Aug; 139(2):351-62. PubMed ID: 9712342 [TBL] [Abstract][Full Text] [Related]
51. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat. Groener JE; van Gent T; van Tol A Biochim Biophys Acta; 1989 Mar; 1002(1):93-100. PubMed ID: 2493808 [TBL] [Abstract][Full Text] [Related]
52. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity. Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786 [TBL] [Abstract][Full Text] [Related]
53. Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol efflux. Chan DC; Hoang A; Barrett PH; Wong AT; Nestel PJ; Sviridov D; Watts GF J Clin Endocrinol Metab; 2012 Sep; 97(9):E1658-66. PubMed ID: 22745238 [TBL] [Abstract][Full Text] [Related]
54. Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I. Leren TP; Bakken KS; Daum U; Ose L; Berg K; Assmann G; von Eckardstein A J Lipid Res; 1997 Jan; 38(1):121-31. PubMed ID: 9034206 [TBL] [Abstract][Full Text] [Related]
55. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease. Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802 [TBL] [Abstract][Full Text] [Related]
56. The plasma concentration of Lpa-I:A-II particles as a predictor of the inflammatory response in patients with ST-elevation myocardial infarction. Gomaraschi M; Sinagra G; Serdoz LV; Pitzorno C; Fonda M; Cattin L; Calabresi L; Franceschini G Atherosclerosis; 2009 Jan; 202(1):304-11. PubMed ID: 18486943 [TBL] [Abstract][Full Text] [Related]
57. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease. Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356 [TBL] [Abstract][Full Text] [Related]